Back to results
US 9,802,976 B2Granted
Method for preparing substituted 3,7-dihydroxy steroids
AssigneeNeurMedix, Inc.
InventorsSteven K. White, Yu Ge, Yujin Huang
Life of this patent
Estimating the term…
Abstract
The invention relates to processes for preparing 17-alkynyl-7-hydroxy-steroids, such as 17-Ethynyl-10R,13S-dimethyl 2,3,4,7,8R,9S,10,11,12,13,14S,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-3R,7R,17S-triol (also referred to as 17α-ethynyl-androst-5-ene-3β,7β,17β-triol), that are essentially free of process impurities having binding activity at nuclear estrogen receptors.
Claims17
A method to make 17α-ethynyl-androst-5-ene-3β,7β,17β-triol essentially free of steroid side-product lacking an oxygen substituent at position 7 comprising the steps of,
- (a) contacting a compound having the structure
- with a reducing agent to convert the ═O functional group at position 7 to hydroxy predominantly in the β-configuration wherein R1 is —H, C1-6 alkyl, C3-6 cycloalkyl, optionally substituted aryl or optionally substituted heteroaryl and R2 is C1-6 alkyl or aryl;
- (b) converting the ═NOR2 group at position 17 in the reaction product from step (a) to a ═O group to obtain a 7β-hydroxy-17-one compound;
- (c) converting the —OC(O)R1 group at position 3 of the 7β-hydroxy-17-one compound to a 3β-hydroxy derivative of the 7β-hydroxy-17-one compound;
- (d) converting the hydroxy groups at positions 3 and 7 in the 3β-hydroxy derivative of the 7β-hydroxy-17-one compound from step (c) to (R3)3SiO— groups, wherein each R3 independently is C1-6 alkyl or aryl;
- and
- (e) contacting the reaction product of step (d) with an compound having the structure of M-C≡C—Si(R5)3, wherein R5 independently are C1-6 alkyl or aryl and M is a Group I, Group II or transition metal, wherein 17α-ethynyl-androst-5-ene-3β,7β,17β-triol essentially free of 17α-alkynyl-androst-5-ene-3β,17β-diol is obtained.
4 more elements
Dependencies are inferred from the claim text.